Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hashemi

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
British Journal of Cancer|November 23, 2016
Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatmentJ L Kuiper, S M S Hashemi, E Thunnissen, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14)R C Boshuizen, V Vd Noort, J A Burgers, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 14, 2019
Epilepsy Gene Therapy Using an Engineered Potassium ChannelAlbert Snowball, Elodie Chabrol, Robert C Wykes, et al.
ERJ Open Research|June 1, 2017
High PD-1 expression on regulatory and effector T-cells in lung cancer draining lymph nodesRieneke van de Ven, Anna-Larissa N Niemeijer, Anita G M Stam, et al.
The European Respiratory Journal|December 23, 2018
Systematic and combined endosonographic staging of lung cancer (SCORE study)Laurence M M Crombag, Christophe Dooms, Jos A Stigt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 27, 2022
Treatment patterns for adrenal metastases using surgery and SABR during a 10-year periodClaire van Vliet, Chris Dickhoff, Idris Bahce, et al.
Cancer|October 31, 2023
A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancerBianca A M H van Veggel, Anthonie J van der Wekken, Marthe S Paats, et al.
Lung Cancer (Amsterdam, Netherlands)|January 12, 2020
Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancerB van Veggel, J F Vilacha Madeira R Santos, S M S Hashemi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2021
Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic AnalysisDavid Planchard, Benjamin Besse, Harry J M Groen, et al.
Targeted Oncology|June 5, 2025
Circulating Tumor DNA in Advanced EGFRex20+ NSCLC: Concordance with Tissue Biopsy, Monitoring of Response, and Resistance to High-Dose OsimertinibFenneke Zwierenga, M Benthe Muntinghe-Wagenaar, Pim Rozendal, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
British Journal of Cancer|November 23, 2016
Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatmentJ L Kuiper, S M S Hashemi, E Thunnissen, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14)R C Boshuizen, V Vd Noort, J A Burgers, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 14, 2019
Epilepsy Gene Therapy Using an Engineered Potassium ChannelAlbert Snowball, Elodie Chabrol, Robert C Wykes, et al.
ERJ Open Research|June 1, 2017
High PD-1 expression on regulatory and effector T-cells in lung cancer draining lymph nodesRieneke van de Ven, Anna-Larissa N Niemeijer, Anita G M Stam, et al.
The European Respiratory Journal|December 23, 2018
Systematic and combined endosonographic staging of lung cancer (SCORE study)Laurence M M Crombag, Christophe Dooms, Jos A Stigt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 27, 2022
Treatment patterns for adrenal metastases using surgery and SABR during a 10-year periodClaire van Vliet, Chris Dickhoff, Idris Bahce, et al.
Cancer|October 31, 2023
A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancerBianca A M H van Veggel, Anthonie J van der Wekken, Marthe S Paats, et al.
Lung Cancer (Amsterdam, Netherlands)|January 12, 2020
Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancerB van Veggel, J F Vilacha Madeira R Santos, S M S Hashemi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2021
Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC: Updated 5-Year Survival Rates and Genomic AnalysisDavid Planchard, Benjamin Besse, Harry J M Groen, et al.
Targeted Oncology|June 5, 2025
Circulating Tumor DNA in Advanced EGFRex20+ NSCLC: Concordance with Tissue Biopsy, Monitoring of Response, and Resistance to High-Dose OsimertinibFenneke Zwierenga, M Benthe Muntinghe-Wagenaar, Pim Rozendal, et al.
Pageof 15